Granted Patent
B2
US 8,278,419 · App. 12/606,382 · Granted Oct 2, 2012
Fibronectin type III domain based scaffold compositions, methods and uses
Assignee:
Centocor Ortho Biotech Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A protein scaffold based on a consensus sequence of fibronectin type III (FN3) proteins, such as the tenth FN3 repeat from human fibronectin (human Tenascin), including isolated nucleic acids that encode a protein scaffold, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices. In particular, protein scaffold molecules binding to IgG have been identified as useful for diagnostic and/or therapeutic applications.
Claims (1)
1. An isolated protein scaffold, comprising the amino acid sequence of SEQ ID NO:16.
Assignments (1)
CHANGE OF NAME
Recorded Sep 24, 2015
From: CENTOCOR ORTHO BIOTECH INC.
To: JANSSEN BIOTECH, INC.
Reel/Frame 036675/0867 →
Continuity (2)
Provisional Application
61110120
· Oct 31, 2008